MedPath

Influence of the depression treatment with escitalopram in mild to moderate arterial hypertensio

Phase 4
Conditions
depressive episode, unspecified
essential (primary) hypertension
F32.9
Registration Number
RBR-5tzcnw
Lead Sponsor
Marcello Finardi Peixoto
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

18 to 65 years; arterial hypertension stage 1 or 2; major depressive disorder

Exclusion Criteria

Liver insuficiency; cardiac insuficiency, renal insuficiency; secundary arterial hypertension; use of psycotropics; psychotic disorder; alcohol or substances disorder; suicide risk

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath